Connection

Daniel Douek to Anti-Retroviral Agents

Back to Details
This is a "connection" page, showing publications Daniel Douek has written about Anti-Retroviral Agents.
Daniel Douek
Connection Strength
0.420
Anti-Retroviral Agents
  1. Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. PLoS Pathog. 2018 08; 14(8):e1007246.
    View in: PubMed
    Score: 0.395
  2. Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction. J Clin Invest. 2018 11 01; 128(11):5083-5094.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.